News
When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat ...
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials Marseille, France, July 18, 2025, 11:00 am CET – ImCheck Therapeutics ...
A webcast and a conference call for analysts, investors and media representatives will be held on Friday, 18 July 2025 at 13.30 EEST. A link to the live webcast is available on Orion's website at ...
Orion Corporation will publish its Financial Statement Release 2025 on Thursday, 12 February 2026. The publication dates of the Interim Reports and the Half-Year Financial Report in 2026 are as ...
Clinical data from the OT‑101 P001 PDAC study suggest targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...
Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, ...
When & Where: Shadow Summit – Monday, July 21 from 10 a.m. to 4:30 p.m. Hidden Valley Resort (next door to the Deerhurst Resort where the Premiers are meeting) 1755 Valley Rd, Huntsville, ON P1H 1A8 ...
Clinical data from the OT‑101 P001 PDAC study suggest that targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly ...
Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of ...
This insider transaction follows prior purchases by other members of the board and the new leadership team and reflects growing alignment and confidence in the Company’s operational progress. Hapbee ...
The RSU awards and stock options were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635 (c) (4) under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results